Wellbutrin online research references









  • Improvement in fluoxetine-associated sexual dysfunction in patients switched to bupropion.
  • The Expert Consensus Guidelines for treating depression in bipolar disorder.
  • Interstitial 3-methoxytyramine reflects striatal dopamine release: an in vivo microdialysis study.
  • Rate of binding of various inhibitors at the dopamine transporter in vivo.
  • Mass spectrometric investigation of 2-aminopropiophenones and some of their metabolites.
  • Antidepressant-associated mania: a controlled comparison with spontaneous mania.
  • Bupropion activation of memory trace retrieval in amnesia and forgetting
  • Lithium and bupropion antagonise the phasic changes in locomotor activity caused by dopamine infused into the rat nucleus accumbens.
  • A comparison of the effects of sibutramine hydrochloride, bupropion and methamphetamine on dopaminergic function: evidence that dopamine is not a pharmacological target for sibutramine.
  • Differentiation of dopamine overflow and uptake processes in the extracellular fluid of the rat caudate nucleus with fast-scan in vivo voltammetry.
  • Brain regional 3Hflunitrazepam binding in rats chronically treated with bupropion or B.W.306U.
  • Effect of plasma from patients containing bupropion and its metabolites on the uptake of norepinephrine.
  • Zyban: a new aid to smoking cessation treatment--will it work for psychiatric patients?
  • Lack of effect of the antidepressant compound bupropion on pineal indoleamines.
  • Prescribing trends of antidepressants in bipolar depression.
  • Treatment of men with major depression: a comparison of sequential cohorts treated with either cognitive-behavioral therapy or newer generation antidepressants.
  • Amphetamine and antidepressant drug effects on GABA- and NMDA-related seizures.
  • Bupropion is a nicotinic antagonist.
  • Effect of dopaminergic drugs on the reserpine-induced lowering of hippocampal theta wave frequency in rats.
  • Acute effects of antidepressants on hippocampal seizures.
  • Bupropion: a new antidepressant drug, the mechanism of action of which is not associated with down-regulation of postsynaptic beta-adrenergic, serotonergic (5-HT2), alpha 2-adrenergic, imipramine and dopaminergic receptors in brain.
  • Behavioral and eegraphic changes induced by dopaminergic antidepressants in rabbits.
  • Smoking cessation. Pulling out the stops.
  • Different effects of the antidepressant drugs imipramine, maprotiline and bupropion on insulin secretion from mouse pancreatic islets.
  • Use of bupropion SR in a pharmacist-managed outpatient smoking-cessation program.
  • Different effects of direct and indirect dopamine receptor agonists on immobility time in reserpine-treated mice.
  • Serotonin-dopamine interactions in the control of conditioned reinforcement and motor behavior.
  • Bupropion induces sniffing: a possible dopaminergic mechanism.
  • State medicaid coverage for tobacco-dependence treatments--United States, 1998 and 2000.
  • Amfebutamone/bupropion for smoking cessation: new preparation. Nicotine replacement therapy is safer.
  • Antidepressant side effects in depression patients treated in a naturalistic setting: a study of bupropion, moclobemide, paroxetine, sertraline, and venlafaxine.
  • Interaction of dopamine D1 and NMDA receptors mediates acute clozapine potentiation of glutamate EPSPs in rat prefrontal cortex.
  • Chronic antidepressant and clonidine treatment effects on conflict behavior in the rat.
  • Rx drugs
  • Marked suppression of gastric ulcerogenesis and intestinal responses to stress by a novel class of drugs.
  • Bupropion inhibits nicotine-evoked (3)Hoverflow from rat striatal slices preloaded with (3)Hdopamine and from rat hippocampal slices preloaded with (3)Hnorepinephrine.
  • Adverse drug reaction update.
  • Self-administration in baboons and the discriminative stimulus effects in rats of bupropion, nomifensine, diclofensine and imipramine.
  • Bupropion exposures: clinical manifestations and medical outcome.
  • Direct evidence of facilitative actions of dopamine in the medial preoptic area on reflexive and noncontact erections in male rats.
  • Evidence that the acute behavioral and electrophysiological effects of bupropion (Wellbutrin) are mediated by a noradrenergic mechanism.
  • Endogenous and exogenous dopamine presynaptically inhibits glutamatergic reticulospinal transmission via an action of D2-receptors on N-type Ca2+ channels.
  • Bupropion enhances brain reward function and reverses the affective and somatic aspects of nicotine withdrawal in the rat.
  • GABAergic modulation of amnesic trace reproduction by activation of the dopaminergic system
  • Effect of bupropion on nicotine self-administration in rats.
  • Characterization of the effects of bupropion on the reinforcing properties of nicotine and food in rats.
  • Influence of complex solubility on formulations based on lambda carrageenan and basic drugs.
  • Effects of bupropion on core body temperature of mice.
  • In vivo activity of bupropion at the human dopamine transporter as measured by positron emission tomography.
  • Treatment of depression. New pharmacologic approaches.
  • The effect of H2-antagonists on the absorption of bupropion in rats.
  • Antagonism of the behavioral effects of cocaine and d-amphetamine by prazosin.
  • Control of prolactin release induced by suckling.
  • Long-term preventive care in depression: the use of bupropion in patients intolerant of other antidepressants.
  • Bupropion in Parkinson's disease.
  • Bupropion as an antidote for serotonin reuptake inhibitor-induced sexual dysfunction.
  • The conditioned place preference paradigm in rats: effect of bupropion.
  • Effects on opioid-induced rate reductions by doxepin and bupropion.
  • Blood levels and acute response to bupropion.
  • Affinity changes of rat striatal dopamine receptors in vivo after acute bupropion treatment.
  • Dopaminergic mediation of the discriminative stimulus effects of bupropion in rats.
  • The pharmacologic basis for therapeutic interest in bupropion.
  • Synthesis and evaluation of the antidepressant activity of the enantiomers of bupropion.
  • Pharmacokinetics of bupropion, a novel antidepressant agent, following oral administration to healthy subjects.
  • Bupropion, d-amphetamine, and amitriptyline-induced conditioned taste aversion in rats: dose effects.
  • Comparative sexual side effects of bupropion, fluoxetine, paroxetine, and sertraline.
  • Antidepressant behavioral effects by dual inhibition of monoamine reuptake in the rat forced swimming test.
  • Comparative analysis of the effects of iontophoretically applied dopamine in different regions of the rat brain, with special reference to the cingulate cortex.







    DreamPharm: Herbal and Nutritional supplements online || Hair Million herbal formula for hair loss and hair growth || Antibiotics and prescription medications online literature ||